$103.17 -0.35 (%) Covance Inc - NYSE

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. 5 Health Care Stocks Hurting From The Affordable Care Act

    Benzinga | Nov. 4, 2014 | 20:46PM EST
  2. UPDATE: Credit Suisse Downgrades Covance Following Agreement To Be Acquired By LH

    Benzinga | Nov. 4, 2014 | 08:37AM EST
  3. Benzinga's M&A Chatter for Monday November 3, 2014

    Benzinga | Nov. 3, 2014 | 19:26PM EST
  4. Covance Jumps On Buy Offer

    IBD | Nov. 3, 2014 | 18:26PM EST
  5. Markets Mixed As Oil Continues To Drop

    Benzinga | Nov. 3, 2014 | 16:37PM EST
  6. Mid-Afternoon Market Update: Covance Surges After LabCorp Deal; American Realty Capital Shares Slide

    Benzinga | Nov. 3, 2014 | 15:11PM EST
  7. Deutsche Bank Defends Laboratory Corp. Of America Following Covance Deal

    Benzinga | Nov. 3, 2014 | 14:38PM EST
  8. Mid-Day Market Update: Ford Falls On October Sales Report; Geron Shares Climb

    Benzinga | Nov. 3, 2014 | 13:20PM EST
  9. Midday Gainers From November 3: Sapient, Covance, Geron And More

    Benzinga | Nov. 3, 2014 | 12:36PM EST
  10. LabCorp Diversifies With $6.1 billion Covance Buyout

    IBD | Nov. 3, 2014 | 12:08PM EST
  11. Merger Monday Mania Roundup

    Benzinga | Nov. 3, 2014 | 11:42AM EST
  12. Mid-Morning Market Update: Markets Mixed; Publicis To Acquire Sapient For $3.7 Billion

    Benzinga | Nov. 3, 2014 | 11:14AM EST
  13. Stocks Open Mixed And Quiet; Chipmakers In Motion

    IBD | Nov. 3, 2014 | 10:35AM EST
  14. Benzinga's Volume Movers

    Benzinga | Nov. 3, 2014 | 10:21AM EST
  15. Morning Market Movers

    Benzinga | Nov. 3, 2014 | 09:38AM EST
  16. Stock Futures Set For Weak Open; Sapient, Covance, FedEx Rising

    IBD | Nov. 3, 2014 | 08:58AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 3, 2014 | 08:09AM EST
  18. UPDATE: Covance Posts In-Line Q3 Earnings

    Benzinga | Nov. 3, 2014 | 08:09AM EST
  19. US Stock Futures Drop Ahead Of Economic Data

    Benzinga | Nov. 3, 2014 | 07:28AM EST
  20. Earnings Scheduled For November 3, 2014

    Benzinga | Nov. 3, 2014 | 05:18AM EST
  21. Contract Researcher Parexel Sees Growth In Biotech

    IBD | Aug. 21, 2014 | 15:00PM EST
  22. WuXi Leverages China's Drug Strength As Outsourcer

    IBD | Feb. 7, 2014 | 18:31PM EST
  23. Morgan Stanley Sees Improving Early Stage for Covance

    Benzinga | Feb. 5, 2014 | 10:11AM EST
  24. Covance Board Authorizes $100M Stock Buyback

    Benzinga | Dec. 19, 2013 | 16:15PM EST
  25. Covance NeoGenomics Enter Strategic Alliance for Anatomic Pathology and Specialty Laboratory Testing Services

    Benzinga | Nov. 18, 2013 | 07:09AM EST
  26. Parexel Plunges After 3 CROs Report Earnings

    IBD | Oct. 30, 2013 | 11:41AM EST
  27. FBN at the Forbes Healthcare Summit

    FoxBusiness | Oct. 10, 2013 | 08:29AM EST
  28. Covance Announces $250M Long-Term Private Placement Debt Financing

    Benzinga | Oct. 8, 2013 | 16:04PM EST
  29. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD | Oct. 4, 2013 | 12:25PM EST
  30. Benzinga's Top Initiations

    Benzinga | Sep. 24, 2013 | 07:44AM EST
  31. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 16:40PM EST
  32. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 16:40PM EST
  33. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, ...

    GuruFocus | Aug. 2, 2013 | 11:25AM EST
  34. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc. ...

    GuruFocus | Aug. 2, 2013 | 11:25AM EST
  35. Benzinga's Top Downgrades

    Benzinga | Aug. 1, 2013 | 07:38AM EST
  36. UPDATE: ISI Group Reiterates Neutral Rating, Raises PT on Covance

    Benzinga | Jan. 28, 2013 | 03:37AM EST
  37. UPDATE: Jefferies Reiterates Hold Rating, Raises PT on Covance

    Benzinga | Jan. 28, 2013 | 02:31AM EST
  38. UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Covance

    Benzinga | Jan. 25, 2013 | 07:30AM EST
  39. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Covance

    Benzinga | Jan. 14, 2013 | 07:11AM EST
  40. Top Narrow Based Indexes For January 14, 2013

    Benzinga | Jan. 14, 2013 | 03:29AM EST
  41. Four European Stocks Worth a Look Now (DLPH, ICLR, IR, LYB)

    Benzinga | Nov. 24, 2012 | 10:02AM EST
  42. Covance, Inc. (CVD) Chairman and CEO Joseph L Herring sells 40,800 Shares

    GuruFocus | Nov. 8, 2012 | 10:39AM EST
  43. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Lowest PEG Ratio

    Benzinga | Nov. 1, 2012 | 21:00PM EST
  44. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest ROA

    Benzinga | Jun. 28, 2012 | 20:05PM EST
  45. Covance Inc. Reports Operating Results (10-K)

    GuruFocus | Feb. 28, 2012 | 06:21AM EST
  46. Stocks Fall As Greek Talks Hit Another Bump With CF Industries (CF) and Priceline (PCLN) on the Move

    MarketIntelligenceCenter | Feb. 14, 2012 | 14:44PM EST
  47. UPDATE: Citigroup Downgrades Covance to Neutral

    Benzinga | Jan. 27, 2012 | 01:18AM EST
  48. Stocks Give Back Early Gains With Hess (HES) and Toll Brothers (TOL) on the Move

    MarketIntelligenceCenter | Jan. 26, 2012 | 14:33PM EST
  49. UPDATE: Goldman Sachs Downgrades Covance to Neutral

    Benzinga | Jan. 26, 2012 | 05:19AM EST
  50. Goldman Sachs Downgrades Covance to Neutral

    Benzinga | Jan. 25, 2012 | 23:10PM EST
Trading Center